BioMarin values a gene therapy for haemophilia in Germany at almost €29,000 per vial

BioMarin Pharmaceutical said the price for the drug to treat severe haemophilia A will be 28,933.53 euros ($31,725.62) per vial for insurers covering most of the population in Germany, Europe’s largest pharmaceutical market.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM